Cardiometabolic Disorders in Women
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 72
Special Issue Editor
Interests: particulate matter air pollution; volatile organic compounds; cardiovascular disease; endothelial progenitor cells; microplastics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular diseases (CVDs) represent a serious global health burden and the leading cause of mortality in women. Cardiovascular diseases in women are still unnoticed and underdiagnosed and consequently not treated in a timely manner.
Obesity and obesity-related disorders, such as insulin resistance, type 2 diabetes, polycystic ovary syndrome, metabolic syndrome, metabolic dysfunction-associated steatotic liver disease and hypertension are closely connected with CVDs. This is more prominent in postmenopausal as compared to premenopausal women, given the hormonal disturbances including estrogen deficiency and hyperandrogenism.
Cardiometabolic disorders share the common underlying pathophysiological traits related to chronic low-grade inflammation and oxidative stress. Even though significant progress has been made regarding this issue, there is still a knowledge gap between the complex pathophysiological mechanisms that underlie cardiometabolic disorders. To gain deeper understanding into the complexness of such mechanisms, much more research is needed for the investigation of some novel diagnostic and prognostic biomarkers for mentioned disorders.
The aim of this Special Issue is to further explore the current trends, advancements and roles of inflammation and oxidative stress in cardiometabolic disorders in female population. Original research and review articles regarding women across their lifespan are welcome.
Potential topics encompass but are not limited to the following:
- The estimation of cardiometabolic risk in women across their lifespan (e.g., adolescence, reproductive age, postmenopause);
- The investigation of the potential novel mechanisms of inflammation/oxidative stress and cardiometabolic disorders in women;
- The recognition of the potential novel biomarkers that are linked to cardiometabolic disorders in women;
- The exploration of the therapeutic possibilities of novel biomarkers in cardiometabolic disorders in women.
Dr. Timothy O'Toole
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiometabolic disorders
- cardiovascular diseases
- women
